Xcout IntelGraph Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Graph Therapeutics among biotech companies — ranked by similarity to what Graph Therapeutics actually does, not by market-cap band.
Subscribe to see Graph Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Graph Therapeutics
Graph Therapeutics is a next-generation techbio company headquartered in Vienna, Austria. The company is involved in developing advanced therapeutic solutions.
Graph Therapeutics at a glance
Graph Therapeutics is a biotech company. Its most recent funding round raised $10M in June 2026.
Graph Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $10M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Graph Therapeutics news
Top 12 Graph Therapeutics competitors
Ranked by semantic similarity — how close each company is to Graph Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Similar biotech company
Arda Therapeutics is a TechBio therapeutics company focused on accelerating pathobiology-driven therapeutic development. The company is headquartered in the San Francisco Bay Area.
Biotechnology
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Life Sciences
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
Biotechnology
HeartBeat.bio is a biotechnology company founded in 2021 and located at the Vienna BioCenter in Austria, specializing in cardiac drug discovery. The company transforms cardiac drug recovery and development using innovative technologies originating from the Institute of Molecular Biotechnology (IMBA).
Biotechnology
Combined Therapeutics is a biotechnology company that develops next-generation mRNA vaccines and immunotherapies for infectious diseases and oncology. The company utilizes a proprietary mRNA platform featuring microRNA binding sequences to target therapeutic protein expression in specific tissues while protecting vital organs from off-target effects.
Biotechnology
Gate2Brain is a biotechnology company dedicated to developing therapeutics that can efficiently cross biological barriers, such as the blood-brain barrier. It was founded as a spin-off from IRB Barcelona, the University of Barcelona, and Hospital Sant Joan de Déu.
Biotechnology
HelixNano is a biotechnology research company headquartered in Boston, Massachusetts, focused on developing advanced mRNA platform technologies for therapeutics.
Similar biotech company
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Biotechnology
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Biotechnology
Affibody AB is a Swedish biopharmaceutical company located in Solna that develops next-generation biopharmaceuticals based on its proprietary Affibody technology platform.
Similar biotech company
Avacta Group Plc operates as a clinical-stage biopharmaceutical company, specializing in the development of cancer therapies and diagnostic solutions. These advancements are driven by its proprietary Affimer and pre|CISION technology platforms, with the company's activities spanning the United Kingdom, North America, South Korea, and broader regions of Asia and Europe. Functioning across distinct Diagnostics and Therapeutics segments, Avacta's diagnostic endeavors include crafting bespoke Affimer proteins for customer products, developing internal diagnostic assays such as the AffiDX SARS-CoV-2 rapid antigen test, and supplying Affimer reagents for integration into third-party offerings. Concurrently, its Therapeutics division is dedicated to pioneering novel cancer immunotherapies through the strategic combination of its proprietary technologies. The company maintains a comprehensive network of collaborations, notably including a research partnership focused on its pre|CISION technology, which utilizes a substrate highly sensitive to cleavage by fibroblast activation protein alpha. Further key alliances encompass a drug development collaboration with LG Chem Life Sciences; a strategic partnership with Tufts University School of Medicine to advance Affimer drug conjugate therapies; a licensing agreement with POINT Biopharma Inc. for the creation of tumor-activated radiopharmaceuticals; and a drug development partnership with AffyXell, aimed at developing engineered mesenchymal stem cells for autoimmune disease treatment. Avacta Group Plc was established in 2003 and is headquartered in Wetherby, United Kingdom.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Graph Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Graph Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →